Why the study?
Does a left ventricular assist device as a bridge to cardiac transplantation improve survival in a patient with refractory peripartum cardiomyopathy?
Does a left ventricular assist device as a bridge to cardiac transplantation improve survival in a patient with refractory peripartum cardiomyopathy?
Answers are grounded in this paper and cite their sources.
LVAD can serve as an effective bridge to cardiac transplantation for patients with severe, refractory peripartum cardiomyopathy.
Peripartum cardiomyopathy is a congestive cardiomyopathy that occurs within the last month of pregnancy or first six months after delivery. Early diagnosis and prompt treatment are of paramount importance. Our patient did not respond to conventional therapy and needed a left ventricular assist device and subsequent orthotopic cardiac transplantation to survive.
No takes yet. Share an insight, caveat, or question.
Hovsepian et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: